A DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IIB, MULTI-CENTER, TWELVE-WEEK PROSPECTIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GEMLAPODECT IN ADULT AND ADOLESCENT PATIENTS WITH TOURETTE SYNDROME

Registry ID

NOE TTS-201

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

NOEMA PHARMA AG

Completion date

2025-10-29

Last update

2025-08-07

Conditions

• TOURETTE'S DISORDER

Related clinical trials

• A MULTICENTER, OPEN-LABEL, STUDY TO EVALUATE THE LONG-TERM SAFETY OF ECOPIPAM TABLETS IN CHILDREN, ADOLESCENTS AND ADULTS WITH TOURETTE¿S DISORDER
• A RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE LONG TERM (IE, MAINTENANCE) EFFICACY OF ORAL ARIPIPRAZOLE IN THE TREATMENT OF PEDIATRIC SUBJECTS WITH TOURETTE¿S DISORDER

View on source registry